Search research articles
Contact Us
Filters
Showing results (171-180 of 271) with videos related to
Page
of 28
Sort By:
Journal of the International Association of Providers of AIDS Care
|
November 22, 2019
Moderately High Tenofovir Diphosphate in Dried Blood Spots Indicates Drug Resistance in Viremic Persons Living with HIV
Jenna Lynn Yager, Ryan Patrick Coyle, Stacey Summer Coleman, et al.
AIDS and Behavior
|
August 19, 2022
Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men
Susan P Buchbinder, Aaron J Siegler, Kenneth Coleman, et al.
The Journal of Antimicrobial Chemotherapy
|
March 4, 2025
Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIV
Vincent A Mainella, Brian Branchford, Travis Nemkov, et al.
The Lancet. HIV
|
March 4, 2021
Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial
Jessica E Haberer, Elizabeth A Bukusi, Nelly R Mugo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 17, 2019
Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing
Matthew A Spinelli, David V Glidden, Peter L Anderson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 3, 2026
An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics
Peter L Anderson, Alina Ps Pang, Ryan P Coyle, et al.
Antimicrobial Agents and Chemotherapy
|
July 30, 2024
Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection
Jihyun Bae, Marwa Tantawy, Yan Gong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 2, 2020
Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus
Sarah C Mann, Mary Morrow, Ryan P Coyle, et al.
AIDS (London, England)
|
July 13, 2017
Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users
Luxi Lal, Jennifer Audsley, Dean A Murphy, et al.
The Lancet. HIV
|
December 4, 2018
Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report
Stephanie E Cohen, Darpun Sachdev, Sulggi A Lee, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 271) with videos related to
Sort By:
Page
of 28
Journal of the International Association of Providers of AIDS Care
|
November 22, 2019
Moderately High Tenofovir Diphosphate in Dried Blood Spots Indicates Drug Resistance in Viremic Persons Living with HIV
Jenna Lynn Yager, Ryan Patrick Coyle, Stacey Summer Coleman, et al.
AIDS and Behavior
|
August 19, 2022
Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men
Susan P Buchbinder, Aaron J Siegler, Kenneth Coleman, et al.
The Journal of Antimicrobial Chemotherapy
|
March 4, 2025
Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIV
Vincent A Mainella, Brian Branchford, Travis Nemkov, et al.
The Lancet. HIV
|
March 4, 2021
Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial
Jessica E Haberer, Elizabeth A Bukusi, Nelly R Mugo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 17, 2019
Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing
Matthew A Spinelli, David V Glidden, Peter L Anderson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 3, 2026
An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics
Peter L Anderson, Alina Ps Pang, Ryan P Coyle, et al.
Antimicrobial Agents and Chemotherapy
|
July 30, 2024
Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection
Jihyun Bae, Marwa Tantawy, Yan Gong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 2, 2020
Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus
Sarah C Mann, Mary Morrow, Ryan P Coyle, et al.
AIDS (London, England)
|
July 13, 2017
Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users
Luxi Lal, Jennifer Audsley, Dean A Murphy, et al.
The Lancet. HIV
|
December 4, 2018
Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report
Stephanie E Cohen, Darpun Sachdev, Sulggi A Lee, et al.
Page
of 28